Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Medicine, Health Care, and Philosophy
|
August 1, 2014
Non-beneficial pediatric research: individual and social interests
Jan Piasecki, Marcin Waligora, Vilius Dranseika
Expert Review of Clinical Pharmacology
|
May 6, 2026
Factors to consider when designing clinical trials for repurposed drugs
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Science and Engineering Ethics
|
November 17, 2016
What Do Ethical Guidelines for Epidemiology Say About an Ethics Review? A Qualitative Systematic Review
Jan Piasecki, Marcin Waligora, Vilius Dranseika
Current Medical Research and Opinion
|
February 2, 2026
Precisely imprecise: therapeutic misconception in precision oncology trials
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Medicine, Health Care, and Philosophy
|
April 29, 2015
Child's objection to non-beneficial research: capacity and distress based models
Marcin Waligora, Joanna Różyńska, Jan Piasecki
BMC Medical Ethics
|
June 14, 2014
Child's assent in research: age threshold or personalisation?
Marcin Waligora, Vilius Dranseika, Jan Piasecki
JAMA Pediatrics
|
November 13, 2018
Participant Protection in Phase 1 Pediatric Cancer Trials
Jonathan Kimmelman, Marcin Waligora, Holly Fernandez Lynch
JAMA Pediatrics
|
April 23, 2019
Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials-Reply
Jonathan Kimmelman, Marcin Waligora, Holly Fernandez Lynch
The American Journal of Bioethics : AJOB
|
August 23, 2018
Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research
Marcin Waligora, Karolina Strzebonska, Mateusz T Wasylewski
Frontiers in Public Health
|
October 6, 2025
Meaningful public involvement: changing research institutions toward epistemic justice
Tomasz Krawczyk, Jan Piasecki, Jacqueline Galica, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Medicine, Health Care, and Philosophy
|
August 1, 2014
Non-beneficial pediatric research: individual and social interests
Jan Piasecki, Marcin Waligora, Vilius Dranseika
Expert Review of Clinical Pharmacology
|
May 6, 2026
Factors to consider when designing clinical trials for repurposed drugs
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Science and Engineering Ethics
|
November 17, 2016
What Do Ethical Guidelines for Epidemiology Say About an Ethics Review? A Qualitative Systematic Review
Jan Piasecki, Marcin Waligora, Vilius Dranseika
Current Medical Research and Opinion
|
February 2, 2026
Precisely imprecise: therapeutic misconception in precision oncology trials
Samuel Gordon, Katarzyna Klas, Marcin Waligora
Medicine, Health Care, and Philosophy
|
April 29, 2015
Child's objection to non-beneficial research: capacity and distress based models
Marcin Waligora, Joanna Różyńska, Jan Piasecki
BMC Medical Ethics
|
June 14, 2014
Child's assent in research: age threshold or personalisation?
Marcin Waligora, Vilius Dranseika, Jan Piasecki
JAMA Pediatrics
|
November 13, 2018
Participant Protection in Phase 1 Pediatric Cancer Trials
Jonathan Kimmelman, Marcin Waligora, Holly Fernandez Lynch
JAMA Pediatrics
|
April 23, 2019
Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials-Reply
Jonathan Kimmelman, Marcin Waligora, Holly Fernandez Lynch
The American Journal of Bioethics : AJOB
|
August 23, 2018
Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research
Marcin Waligora, Karolina Strzebonska, Mateusz T Wasylewski
Frontiers in Public Health
|
October 6, 2025
Meaningful public involvement: changing research institutions toward epistemic justice
Tomasz Krawczyk, Jan Piasecki, Jacqueline Galica, et al.
Page
of 4